Tradestie Institutional Equity Comparison Engine

CRMD vs FDMT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while FDMT counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CRMD trades at 29.5x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus FDMT at N/M Forward P/E and -222.7% operating margin (+4505.6% YoY). In options structure, CRMD sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro) against FDMT sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CRMD 29.5x vs FDMT N/M Fwd P/E
Growth & Margin Winner CRMD
Op Margin 41.0% vs -222.7% ยท YoY -47.7% vs +4505.6%
Momentum & Technical Winner FDMT
1Y -58.2% vs -0.5% ยท 52W Pos 1% vs 38%
Options & Structure Winner FDMT
BREAKDOWN (22nd %ile IV) vs BREAKDOWN (10th %ile IV)
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.70
-2.59% 1D
Market Cap $370.6M
1M Return -36.38%
1Y Return -58.23%
Forward P/E 29.5x
Unified AI Score
55.5 / 100 HOLD
Tech 60.0 Fund 62.0 Flow 70.0 Mom 55.0
FDMT NASDAQ
4D Molecular Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$10.74
-4.87% 1D
Market Cap $689.5M
1M Return -12.61%
1Y Return -0.46%
Forward P/E N/M
Unified AI Score
41.5 / 100 SELL
Tech 40.0 Fund 56.0 Flow 63.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRMD -58.23% FDMT -0.46% Spread: +57.77 pp (FDMT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRMD Revenue FDMT Revenue CRMD Op. Margin FDMT Op. Margin Margin Edge
FY2018 $0M N/A -6250.4% N/A CRMD
FY2019 $0M $10M -7416.3% -729.4% FDMT
FY2020 $0M $10M -11378.4% -424.0% FDMT
FY2021 $0M $20M -15417.5% -395.5% FDMT
FY2022 $0M $0M -46819.9% -3516.5% FDMT
FY2023 N/A $20M N/A -544.6% FDMT
FY2024 $40M $0M -51.4% -507678.4% CRMD
FY2025 $310M $90M 48.2% -187.2% CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRMD (6) vs FDMT (4)
Institutional Metric CRMD FDMT Criterion Row Winner
Market Capitalization Scale $370.6M $689.5M Larger Scale FDMT
Trailing P/E Ratio Valuation 2.4x N/M Lower Multiple CRMD
Forward P/E Ratio Valuation 29.5x N/M Lower Multiple CRMD
Revenue Growth (YoY) Growth -47.7% +4505.6% Higher Growth FDMT
Operating Margin (TTM) Profitability 41.0% -222.7% Higher Margin CRMD
Net Profit Margin Profitability 15.5% -208.6% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency 15.3% -56.7% Higher ROE CRMD
52-Week Range Position Momentum 1% ($5โ€“$13) 38% ($7โ€“$17) Stronger Trend FDMT
Beta / 30D Volatility Risk Regime 1.22ฮฒ ยท 103% Vol 1.96ฮฒ ยท 93% Vol Lower Realized Risk FDMT
Unified Institutional Score Composite Signal 55.5 / 100 (HOLD) 41.5 / 100 (SELL) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRMD vs FDMT Buy Guide
CRMD BREAKDOWN
110d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FDMT BREAKDOWN
63d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live FDMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRMD nor FDMT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.